liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Dosing Patterns In Treatment of Disabling Spasticity With Intrathecal Baclofen
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Anaesthetics, Operations and Specialty Surgery Center, Department of Rehabilitation Medicine.
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Anaesthetics, Operations and Specialty Surgery Center, Pain and Rehabilitation Center.
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Nursing Sciences and Reproductive Health. Linköping University, Faculty of Medicine and Health Sciences.
Uppsala Univ, Sweden.
Show others and affiliations
2021 (English)In: REHABILITATION NURSING, ISSN 0278-4807, Vol. 46, no 6, p. 315-322Article in journal (Refereed) Published
Abstract [en]

Purpose The aim of this study was to describe and analyze dosing patterns for patients with ITB treatment over time and to identify possible subgroups demonstrating diversity in patterns. Design A retrospective design. Methods For 81 patients from six different hospitals, baclofen doses from the first 2 years of treatment were identified using medical records. Line graphs of each patients doses were analyzed and grouped based on similarities in dosing pattern. Findings The analyses of the dosing patterns resulted in four different subgroups classified as stable, slow increase, rapid increase, and fluctuating. Conclusion The results highlight the clinical challenge of predicting dose development over time.

Place, publisher, year, edition, pages
LIPPINCOTT WILLIAMS & WILKINS , 2021. Vol. 46, no 6, p. 315-322
Keywords [en]
Dosing patterns; spasticity; intrathecal baclofen
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:liu:diva-181056DOI: 10.1097/RNJ.0000000000000323ISI: 000713723600007PubMedID: 33788806OAI: oai:DiVA.org:liu-181056DiVA, id: diva2:1612384
Note

Funding Agencies|County Council of Ostergotland; Medical Research Council of Southeast SwedenUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Swedish Association of Persons With Neurological Disabilities

Available from: 2021-11-18 Created: 2021-11-18 Last updated: 2022-10-21
In thesis
1. What makes a patient satisfied with intrathecal baclofen treatment for spasticity: Expectations and experiences
Open this publication in new window or tab >>What makes a patient satisfied with intrathecal baclofen treatment for spasticity: Expectations and experiences
2022 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Patients often report reduced spasticity and/or pain, improved function and comfort, and a high level of satisfaction after treatment with intrathecal baclofen (ITB). However, dissatisfaction, complications and unmet goals are also reported. The overall aim of the thesis was to identify, describe, and analyse what makes a patient satisfied with the effect of ITB treatment for spasticity, by considering patient expectations, experience, outcome, as well as satisfaction with treatment.  

Four studies are included, all focusing on patients undergoing ITB treatment or about to start treatment. Study I, a qualitative interview study, describes the experiences of 14 patients on ITB from one university hospital. Study II, a cross-sectional study, includes 6 of the 7 main hospitals in Sweden working with ITB treatment. Through questionnaires and medical records, data were collected from 83 patients, on general expectations/optimism, satisfaction with treatment and reports on complications. Study III is based on data from study II on baclofen doses for 81 patients to analyse the development of dose patterns. Study IV, a prospective longitudinal study, includes 29 patients from 2 university hospitals. Data collection focused on pre-expectations, effect at 1-year follow-up and satisfaction with treatment. The results of the thesis are summarized in 3 topics: (1) variables of interest for formulation of patients’ pre-expectations; (2) pre-expectations of outcome and ongoing ITB treatment; (3) outcomes and satisfaction with ITB treatment. Together, those topics describe what makes a patient satisfied with ITB treatment. Patients reported improvements in symptoms and reduced consequences from spasticity, however improvements were not always as good as expected. Reported satisfaction with ITB treatment varied in the 4 studies, but mostly a high level of satisfaction was reported. Variables of importance for satisfaction were improved occupational performance, pre-expectations met and initial status regarding occupational performance.  

In conclusion, results from this thesis emphasize the need for a dialogue between the patient and health care professionals to enable the formulation of realistic individual pre-expectations and goals. In addition, unmet pre-expectations, complications and frequent hospital visits should be included in the discussion about the benefits of ITB treatment versus the disadvantages. 

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2022. p. 76
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 1819
Keywords
Interview, Intrathecal baclofen, Multivariate analyses, Occupational performance, Optimism, Pain intensity, Preexpectations, Satisfaction, Self-efficacy, Spasticity.
National Category
Social and Clinical Pharmacy
Identifiers
urn:nbn:se:liu:diva-189424 (URN)10.3384/9789179294298 (DOI)9789179294281 (ISBN)9789179294298 (ISBN)
Public defence
2022-12-09, Berzeliussalen, Building 463, Campus US, Linköping, 09:00 (Swedish)
Opponent
Supervisors
Available from: 2022-10-21 Created: 2022-10-21 Last updated: 2022-10-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Gunnarsson, StinaLemming, DagAlehagen, SiwErtzgaard, PerSamuelsson, Kersti
By organisation
Division of Prevention, Rehabilitation and Community MedicineFaculty of Medicine and Health SciencesDepartment of Rehabilitation MedicinePain and Rehabilitation CenterDivision of Nursing Sciences and Reproductive Health
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 49 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf